CE VIDEO: New Frontiers in Frontline Ocular Surface Care

 Lessons from DEWS II on best practices for dry eye disease diagnosis, treatment and management.
Sponsored by Shire.

Speakers: Lyndon Jones, PhD, FCOptom, FAAO; Paul M. Karpecki, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Leslie O’Dell, OD, FAAO

Release Date:

February 16, 2018

Expiration Date:

February 28, 2019

Goal Statement: 

On completion of this educational activity, optometrists should understand why a thorough exam of the ocular surface and adnexa are essential aspects of optometric care, and be able to perform a proper evaluation of the ocular surface that will provide more definitive diagnoses, as well as highlight new research on the inflammatory pathway and ocular surface disease treatments.

Faculty/Editorial Board:

Lyndon Jones, PhD, FCOptom, FAAO; Paul M. Karpecki, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Leslie O’Dell, OD, FAAO

Credit Statement: 

This course is COPE approved for 2 hours of CE credit. COPE ID is 56689-AS. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.

Joint-Sponsorship Statement: 

This continuing education course is joint sponsored by the University of Alabama School of Optometry.

Disclosure Statement: 

Dr. Jones is a consultant for Alcon, CooperVision and J&J Vision; and a principal investigator for Alcon, Allergan, CooperVision, GL Chemtech, J&J Vision, Nature’s Way, Novartis, Santen and Shire Pharmaceuticals.
Dr. Nichols is a consultant for Bruder Healthcare Company, InSite Vision, Parion Pharmaceuticals, SARcode Bioscience, Shire Pharmaceuticals, Sun Pharmaceuticals, Kala Pharmaceutical, Eleven Biotherapeutics, Science Based Health, Allergan, Santen Pharmaceutical.
Dr. Karpecki is a consultant for Aerie Pharmaceuticals, Alcon, Abbott Medical Optics, Akorn, Allergan, Anthem Bausch + Lomb, Bio-Tissue, BlephEx, Beaver-Visitec, Bruder Healthcare,  Cambium Pharma,  Essilor, Eyes4Lives,  Focus Labs, Glaukos,  iCare USA, Imprimis Pharmaceuticals, J&J, Konan Medical, Maculogix, Oasis, Ocular Therapeutix, Oculus, OcuSoft, Regeneron, SightRisk, Reichert, Shire Pharmaceuticals, Science Based Health, Smart Vision Labs, TearScience, Topcon, TLC Vision, Vision Care Inc., Vmax and Visiometrics; a research grant principal investigator for Eleven BioTherapeutics, Fera Pharmaceuticals, Shire Pharmaceuticals; has received honoraria for the speaker’s bureaus of Glaukos and Oculus; is director/clinical advisor for Optometric Medical Solutions; and is on the board of directors for TearLab. 

Dr. O'Dell is a consultant to Eye Eco and Shire Pharmaceuticals; and a speaker for Allergan, Shire and Genyzme.

Supported by: An unrestricted educational grant from Shire.

Watch this online distance learning course and click the link below to take the exam for 2 hours of CE credit.